143 related articles for article (PubMed ID: 36935568)
1. Benefits and risks evaluation of recombinant human growth hormone replacement therapy in children with GHD after craniopharyngioma surgery.
Pei LL; Guo Y; Chen H; Zhong LY
J Pediatr Endocrinol Metab; 2023 May; 36(5):484-491. PubMed ID: 36935568
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and growth hormone (GH) therapy in children with GH deficiency: experience in King Chulalongkorn Memorial Hospital, Thailand.
Wacharasindhu S; Supornsilchai V; Aroonparkmongkol S; Srivuthana S
J Med Assoc Thai; 2007 Oct; 90(10):2047-52. PubMed ID: 18041422
[TBL] [Abstract][Full Text] [Related]
4. Growth response to growth hormone (GH) treatment in children with GH deficiency (GHD) and those with idiopathic short stature (ISS) based on their pretreatment insulin-like growth factor 1 (IGFI) levels and at diagnosis and IGFI increment on treatment.
Soliman A; Rogol AD; Elsiddig S; Khalil A; Alaaraj N; Alyafie F; Ahmed H; Elawwa A
J Pediatr Endocrinol Metab; 2021 Oct; 34(10):1263-1271. PubMed ID: 34291621
[TBL] [Abstract][Full Text] [Related]
5. Effects of 18-month of growth hormone (GH) replacement therapy in patients with Sheehan's syndrome.
Tanriverdi F; Unluhizarci K; Kula M; Guven M; Bayram F; Kelestimur F
Growth Horm IGF Res; 2005 Jun; 15(3):231-7. PubMed ID: 15921942
[TBL] [Abstract][Full Text] [Related]
6. Growth in children with craniopharyngioma following surgery.
Tiulpakov AN; Mazerkina NA; Brook CG; Hindmarsh PC; Peterkova VA; Gorelyshev SK
Clin Endocrinol (Oxf); 1998 Dec; 49(6):733-8. PubMed ID: 10209560
[TBL] [Abstract][Full Text] [Related]
7. Metabolic effects of growth hormone (GH) replacement in children and adolescents with severe isolated GH deficiency due to a GHRH receptor mutation.
Gleeson H; Barreto ES; Salvatori R; Costa L; Oliveira CR; Pereira RM; Clayton P; Aguiar-Oliveira MH
Clin Endocrinol (Oxf); 2007 Apr; 66(4):466-74. PubMed ID: 17371461
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of recombinant human growth hormone in treating Chinese children with idiopathic short stature.
Ying YQ; Hou L; Liang Y; Wu W; Luo XP
Growth Horm IGF Res; 2018; 42-43():80-85. PubMed ID: 30343148
[TBL] [Abstract][Full Text] [Related]
9. Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment.
Feigerlová E; Diene G; Oliver I; Gennero I; Salles JP; Arnaud C; Tauber M
J Clin Endocrinol Metab; 2010 Oct; 95(10):4600-8. PubMed ID: 20926543
[TBL] [Abstract][Full Text] [Related]
10. Effect of growth hormone treatment on children with idiopathic short stature (ISS), idiopathic growth hormone deficiency (IGHD), small for gestational age (SGA) and Turner syndrome (TS) in a tertiary care center.
Al Shaikh A; Daftardar H; Alghamdi AA; Jamjoom M; Awidah S; Ahmed ME; Soliman AT
Acta Biomed; 2020 Mar; 91(1):29-40. PubMed ID: 32191651
[TBL] [Abstract][Full Text] [Related]
11. Atherogenic lipoprotein phenotype and low-density lipoprotein size and subclasses in patients with growth hormone deficiency before and after short-term replacement therapy.
Rizzo M; Trepp R; Berneis K; Christ ER
Eur J Endocrinol; 2007 Mar; 156(3):361-7. PubMed ID: 17322496
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Safety and Efficacy of Growth Hormone Therapy by IGF-1 Z Score in Children with Short Stature.
Liu HJ; Wang LH; Chen L
Adv Ther; 2019 Sep; 36(9):2374-2383. PubMed ID: 31301056
[TBL] [Abstract][Full Text] [Related]
13. GH and Childhood-onset Craniopharyngioma: When to Initiate GH Replacement Therapy?
Nguyen Quoc A; Beccaria K; González Briceño L; Pinto G; Samara-Boustani D; Stoupa A; Beltrand J; Besançon A; Thalassinos C; Puget S; Blauwblomme T; Alapetite C; Bolle S; Doz F; Grill J; Dufour C; Bourdeaut F; Abbou S; Guerrini-Rousseau L; Leruste A; Brabant S; Cavadias I; Viaud M; Boddaert N; Polak M; Kariyawasam D
J Clin Endocrinol Metab; 2023 Jul; 108(8):1929-1936. PubMed ID: 36794424
[TBL] [Abstract][Full Text] [Related]
14. Baseline characteristics and response to 2 years of growth hormone (GH) replacement of hypopituitary patients with GH deficiency due to adult-onset craniopharyngioma in comparison with patients with nonfunctioning pituitary adenoma: data from KIMS (Pfizer International Metabolic Database).
Verhelst J; Kendall-Taylor P; Erfurth EM; Price DA; Geffner M; Koltowska-Häggström M; Jönsson PJ; Wilton P; Abs R
J Clin Endocrinol Metab; 2005 Aug; 90(8):4636-43. PubMed ID: 15928246
[TBL] [Abstract][Full Text] [Related]
15. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G
Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581
[TBL] [Abstract][Full Text] [Related]
16. Effect of different doses of recombinant human growth hormone therapy on children with growth hormone deficiency: a retrospective observational study.
Yang T; Zha W; Liang X; Xu Q; Guo TT; He X; Yuan Y; Zhang G
Eur Rev Med Pharmacol Sci; 2023 Jul; 27(13):6162-6169. PubMed ID: 37458672
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone and the risk of atherosclerosis in growth hormone-deficient children.
Binay C; Simsek E; Yıldırım A; Kosger P; Demiral M; Kılıç Z
Growth Horm IGF Res; 2015 Dec; 25(6):294-7. PubMed ID: 26296621
[TBL] [Abstract][Full Text] [Related]
18. Vasculometabolic effects in patients with congenital growth hormone deficiency with and without GH replacement therapy during adulthood.
Biscotto IP; Costa Hong VA; Batista RL; Mendonca BB; Arnhold IJP; Bortolotto LA; Carvalho LRS
Pituitary; 2021 Apr; 24(2):216-228. PubMed ID: 33098037
[TBL] [Abstract][Full Text] [Related]
19. Proposal of a clinical response score and predictors of clinical response to 2 years of GH replacement therapy in adult GH deficiency.
Schneider HJ; Buchfelder M; Wallaschofski H; Luger A; Johannsson G; Kann PH; Mattsson A
Eur J Endocrinol; 2015 Dec; 173(6):843-51. PubMed ID: 26369579
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the efficacy and safety of recombinant human growth hormone in treating idiopathic short stature and growth hormone deficiency in children.
Hou L; Liang Y; Wu W; Lin HH; Luo XP; Ying YQ
Growth Horm IGF Res; 2020; 53-54():101331. PubMed ID: 32777706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]